Sleeves up for DNA jab

The first human trial of a needle-free DNA Covid jab, developed by researchers at the University of Adelaide is set to start this week.

Enough doses of the vaccine have already been manufactured at BioCina's plant in the Adelaide suburb of Thebarton, which it bought from Pfizer late last year.

Lead investigator and Head of Viral Immunology at the University of Adelaide's Medical School, Associate Professor Branka Grubor-Bauk, is calling on volunteers who are over the age of 18, triple vaccinated more than three months ago and have not had COVID-19, to put their hand up for the trial.